Clinical Trials in Hematology and Medical Oncology

hospital building

Clinical Trials

Clinical trials are research studies that test new treatments to see how well they work. At the University of Vermont Cancer Center, patients who choose to participate in a trial receive some of the most advanced cancer treatment available, sometimes years before it’s available at other hospitals.

University of Vermont Cancer Center Clinical Trials

Clinical Trials

Body

Several faculty in the Division are Principle Investigators for clinical trials administered by the University of Vermont Cancer Center Clinical Trials Office (UVMCC CTO). At the UVMCC, we encourage our patients from all races, genders, ages, and backgrounds to consider participating in a clinical trial from the start of their care. If you join a UVMCC clinical trial, you will be cared for by experienced healthcare providers and researchers. 

 

Safety in Clinical Trials

Body

If you join a UVMCC clinical trial, you will be cared for by experienced healthcare providers and researchers. It is possible the treatment in a clinical trial may not work, it may cause unwarranted side effects. Clinical trial participation may help other people, but not you. Whatever the outcome, clinical trials are designed to keep you safe. Researchers must follow strict rules, and every clinical trial is approved and monitored by an institutional review board and government agencies that ensure your safety. The Institutional Review Board (IRB) office at UVM ensures the risks are as low as possible and that there are more benefits than risks. Its job is to ensure that each clinical trial is ethical and protects our patient’s rights. 

Clinical Trials

The Basics

Body

Almost every cancer treatment offered to patients today has come about because of a clinical trial. 

The goals of individual clinical trials vary. They range from looking at new, potentially curative therapies to ones with fewer side effects.

Patients who enroll in a clinical trial at UVMCC receive a very high level of care and treatment from a compassionate and experienced staff recognized for their focus on safety and care.

A clinical trial may take more time for treatment than normal care. There can be more visits, phone calls, treatments, a hospital stay, or more complicated treatments.

There are no additional out-of-pocket costs to patients for treatments being studied as part of a trial.

The vast majority of clinical trials do not use a placebo. For clinical trials that do, patients will be fully informed before they begin the trial.

More about the UVMCC CTO

Body

Clinical trials are integral to any cancer center. Patients at the University of Vermont Cancer Center (UVMCC) have access to a range of clinical trials offered through a centralized infrastructure. The UVMCC’s Clinical Trials Office (CTO) supports the collaborative efforts of its dedicated physician investigators and researchers to pioneer ground-breaking advancements in clinical and translational cancer research to better the lives of our patients and survivors. The CTO has a clearly defined and recognized reporting and accountability structure, upholds the highest standards of clinical research, provide professional research personnel, and efficient, dependable processes to support the ethical and compliant conduct of cancer clinical research. 

More about our physician investigators

Body

Our physician investigators and the CTO personnel have specialized training to ensure patient safety, regulatory compliance, and data integrity while enhancing the lives of those at risk for and affected by cancer. With the CTO, the UVMCC physician investigators plan clinical trials very carefully. Together, they closely watch over people in the trial, and they follow rules to manage any problems and can stop the trial if something does not seem right. The CTO serves as a central point of contact, coordinating closely with clinical trial participants, your physicians, regulatory authorities, investigational pharmacy, laboratory services, compliance committees, and sponsors. 

More about our CTO portfolio

Body

The CTO oversees a portfolio of institutionally sponsored, externally peer-reviewed, industry-sponsored, and National Cancer Institute (NCI) National Clinical Trials Network (NCTN) studies.